RecruitingNCT06409013

Evaluation of Tumor Resection Guided by Intraoperative Indocyanine Green Dye Fluorescence Angiography in Patients With Sarcoma

Sarcoma Resection Guided by Intraoperative Indocyanine Green Dye Fluorescence Angiography


Sponsor

Mayo Clinic

Enrollment

50 participants

Start Date

Mar 14, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

This study evaluates the effectiveness of intraoperative indocyanine green dye and fluoroscopic technology in confirming negative margins after tumor removal.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether a special fluorescent dye (indocyanine green, or ICG) used during surgery can help surgeons better see the edges of bone and soft tissue sarcomas (rare cancers of bones and connective tissue) to ensure they remove the entire tumor. **You may be eligible if...** - You have been diagnosed with bone or soft tissue sarcoma confirmed by biopsy - You are 18 years or older - You are scheduled for surgery to remove the tumor **You may NOT be eligible if...** - You are under 18 years old - You have chronic kidney disease - You have had a severe allergic reaction to dyes or contrast agents in the past Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNon-Interventional Study

Non-interventional study


Locations(1)

Mayo Clinic in Rochester

Rochester, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06409013


Related Trials